Return To Office: Pfizer To Enforce 2-3 Days In Office Starting January

Pfizer Inc's PFE CEO Albert Bourla said the U.S. employees would have to return to their workplaces two to three days a week starting in January.
About one-third of Pfizer's employees have still not returned to the office as concerns about the pandemic have begun fading, Bourla said in a panel discussion at the Paley International Council Summit in New York.
Pfizer joined forces with BioNTech SE BNTX to develop one of the first COVID-19 vaccines at top speed during the pandemic when many employees were working from home and then generated the Paxlovid pill for treating people at high risk of severe disease.
Both products have been highly successful for the company.
Related: Pfizer's Q3 Earnings Surpasses Estimates, Lifts Forecasts For COVID-19 Vaccine Sales By $2B.
"I started to worry we were going to lose the DNA of our company, the feeling of family," Bourla said in the discussion. "For our workforce, people with office-type jobs, we are asking them, and will start enforcing a two to three days" of weekly attendance, he said.
"We're trying to see how we can play our cards so that we can save the world once again," Bourla said.
Price Action: PFE shares are down 0.55% at $47.09 during the premarket session on the last check Wednesday.